Blue Zone Wealth Advisors LLC Boosts Stock Holdings in Relx Plc $RELX

Blue Zone Wealth Advisors LLC boosted its position in Relx Plc (NYSE:RELX) by 0.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 124,187 shares of the technology company’s stock after purchasing an additional 346 shares during the period. Relx comprises approximately 1.7% of Blue Zone Wealth Advisors LLC’s portfolio, making the stock its 23rd biggest holding. Blue Zone Wealth Advisors LLC’s holdings in Relx were worth $6,748,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of RELX. Rhumbline Advisers lifted its stake in Relx by 1.2% in the first quarter. Rhumbline Advisers now owns 34,906 shares of the technology company’s stock valued at $1,760,000 after purchasing an additional 411 shares during the last quarter. Farther Finance Advisors LLC lifted its stake in Relx by 2.0% in the first quarter. Farther Finance Advisors LLC now owns 22,886 shares of the technology company’s stock valued at $1,160,000 after purchasing an additional 448 shares during the last quarter. GAMMA Investing LLC lifted its stake in Relx by 23.5% in the first quarter. GAMMA Investing LLC now owns 13,471 shares of the technology company’s stock valued at $679,000 after purchasing an additional 2,563 shares during the last quarter. SG Americas Securities LLC lifted its stake in Relx by 4.0% in the first quarter. SG Americas Securities LLC now owns 64,071 shares of the technology company’s stock valued at $3,230,000 after purchasing an additional 2,493 shares during the last quarter. Finally, Simon Quick Advisors LLC purchased a new position in Relx in the first quarter valued at approximately $241,000. Hedge funds and other institutional investors own 15.02% of the company’s stock.

Analysts Set New Price Targets

RELX has been the topic of a number of analyst reports. Barclays reissued an “overweight” rating on shares of Relx in a report on Tuesday. Morgan Stanley reissued an “overweight” rating on shares of Relx in a report on Thursday, September 11th. Kepler Capital Markets raised shares of Relx from a “hold” rating to a “strong-buy” rating in a report on Thursday, September 18th. Wall Street Zen cut shares of Relx from a “buy” rating to a “hold” rating in a report on Friday, September 5th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Relx in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the company. According to data from MarketBeat, Relx currently has a consensus rating of “Buy”.

Relx Trading Down 0.8%

Relx stock opened at $44.80 on Friday. The stock has a market cap of $81.87 billion, a P/E ratio of 24.08, a PEG ratio of 2.94 and a beta of 0.87. Relx Plc has a fifty-two week low of $44.19 and a fifty-two week high of $56.33. The firm’s fifty day moving average price is $47.22 and its 200-day moving average price is $50.80. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47.

Relx Cuts Dividend

The company also recently declared a semi-annual dividend, which was paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th were issued a $0.2634 dividend. The ex-dividend date of this dividend was Friday, August 8th. This represents a dividend yield of 170.0%. Relx’s dividend payout ratio is presently 28.49%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.